We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CytomX Announces Third Target Selection by BMS

News   Jan 21, 2016

 
CytomX Announces Third Target Selection by BMS
 
 
Advertisement
 

RELATED ARTICLES

New Strain of Swine Flu Is Something We "Need To Keep Our Eye On"

News

A study published June 29 in the journal Proceedings of the National Academy of Sciences (PNAS) has drawn attention to a new strain of the H1N1 virus, known as G4 EA H1N1, with report describing the strain as having "pandemic potential".

READ MORE

SARS-CoV-2 Immunity Likely To Be Higher Than Antibody Testing Has Shown

News

A recent study suggests that many people who contract SARS-CoV-2 but have mild or no clinical signs still develop so-called T-cell-mediated immunity to the virus, even in the absence of a positive antibody test. The researchers conclude that this is likely to mean that public immunity is probably higher than antibody testing has so far suggested.

READ MORE

Rewriting the Rules of Vaccine Design With DNA Origami

News

By folding DNA into a virus-like structure, MIT researchers have designed HIV-like particles that provoke a strong immune response from human immune cells grown in a lab dish. Such particles might eventually be used as an HIV vaccine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE